Hartwig F. Klinker

Oberdürrbacher Str. 6
Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

Health-Related Quality of Life in Previous Versus Current Opiate Users Receiving HCV Therapy: Registry-Based Evidence.

Health-Related Quality of Life in Previous Versus Current Opiate Users Receiving HCV Therapy: Registry-Based Evidence.

Journal: Brain sciences

Published: February 27, 2026

Resolved HBV Infection Is Not Associated With Liver-Related Outcomes in Survival Analysis of Caucasians After HCV Cure.

Resolved HBV Infection Is Not Associated With Liver-Related Outcomes in Survival Analysis of Caucasians After HCV Cure.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 09, 2025

Impact of distinct antiviral treatment regimens on the long-term outcome after HCV cure - Data from the German Hepatitis C-Registry (DHC-R).

Impact of distinct antiviral treatment regimens on the long-term outcome after HCV cure - Data from the German Hepatitis C-Registry (DHC-R).

Journal: Zeitschrift fur Gastroenterologie

Published: May 13, 2025

Model-based assessment of letermovir pharmacokinetics in allogeneic haematopoietic stem cell transplant recipients.

Model-based assessment of letermovir pharmacokinetics in allogeneic haematopoietic stem cell transplant recipients.

Journal: The Journal of antimicrobial chemotherapy

Published: May 06, 2025

Breastfeeding on ART and a closer look at drug transfer to HIV-exposed uninfected infants.

Breastfeeding on ART and a closer look at drug transfer to HIV-exposed uninfected infants.

Journal: Scientific reports

Published: March 04, 2025

Therapeutic Drug Monitoring of Long-Acting Rilpivirine and Cabotegravir for Treatment of HIV-1 Infection-A Case Series of Five Patients With One Virologic Failure After Development of Two-Class Resistance.

Therapeutic Drug Monitoring of Long-Acting Rilpivirine and Cabotegravir for Treatment of HIV-1 Infection-A Case Series of Five Patients With One Virologic Failure After Development of Two-Class Resistance.

Journal: Open forum infectious diseases

Published: May 01, 2024

Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort.

Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort.

Journal: Infection

Published: January 09, 2024

Clinical validation and assessment of feasibility of volumetric absorptive microsampling (VAMS) for monitoring of nilotinib, cabozantinib, dabrafenib, trametinib, and ruxolitinib.

Clinical validation and assessment of feasibility of volumetric absorptive microsampling (VAMS) for monitoring of nilotinib, cabozantinib, dabrafenib, trametinib, and ruxolitinib.

Journal: Journal of pharmaceutical and biomedical analysis

Published: December 23, 2022

Viral break through during dolutegravir-based antiretroviral therapy after excessive consumption of fruit juices.

Viral break through during dolutegravir-based antiretroviral therapy after excessive consumption of fruit juices.

Journal: AIDS (London, England)

Published: December 08, 2022

A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug-Drug Interaction Frequently Observed in Graft versus Host Disease Patients.

A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug-Drug Interaction Frequently Observed in Graft versus Host Disease Patients.

Journal: Pharmaceutics

Published: October 24, 2022

Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma.

Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma.

Journal: Cancers

Published: August 04, 2022

Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R).

Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R).

Journal: Zeitschrift fur Gastroenterologie

Published: July 15, 2022

Showing 1-12 of 90

Last Updated: 09/26/2026